Amble vs NiceRx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
NiceRx
Best for patients seeking batch-tested compounded GLP-1 with transparent entity disclosureStarting at $199/mo
Side-by-Side Comparison
| Feature | Amble | NiceRx |
|---|---|---|
| Overall Score | 7.4/10 | ✓7.6/10 |
| Starting Price | ✓$179/mo | $199/mo |
| Editorial Rating | 3.7 ★ /5 | ✓3.8 ★ /5 |
| Features | 3 features | ✓4 features |
| States Available | ✓50 | 46 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
NiceRx
Pros
- ✓LegitScript approved
- ✓Named legal entity (NiceRx LLC) with Boca Raton FL address
- ✓First-month discount on both drugs
- ✓Every batch tested for sterility and potency
- ✓46-state coverage
- ✓Microdose options available
- ✓Founded 2022 — established track record
Cons
- ✗Not available in Alaska, Mississippi, New Jersey, Kansas
- ✗Compounded only — no brand-name options
- ✗Broader platform (anti-aging, NAD+, B12)
Our Verdict
NiceRx edges out Amble with a higher overall score of 7.6/10 and is particularly strong for patients seeking batch-tested compounded GLP-1 with transparent entity disclosure. Amble remains a solid alternative, especially if you're looking for mainstream telehealth GLP-1 access.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.